Operating Lease, Right-of-Use Asset of Akoya Biosciences, Inc. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Akoya Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
Akoya Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $3,859,000, a 31% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Akoya Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$3,859,000	-$1,709,000	-31%	31 Mar 2025	10-Q	13 May 2025	2025	Q1
Q4 2024	$4,255,000	-$4,110,000	-49%	31 Dec 2024	10-Q	13 May 2025	2025	Q1
Q3 2024	$4,664,000	-$4,339,000	-48%	30 Sep 2024	10-Q	14 Nov 2024	2024	Q3
Q2 2024	$5,154,000	-$4,475,000	-46%	30 Jun 2024	10-Q	06 Aug 2024	2024	Q2
Q1 2024	$5,568,000	-$4,619,000	-45%	31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$8,365,000	-$2,420,000	-22%	31 Dec 2023	10-K	17 Mar 2025	2024	FY
Q3 2023	$9,003,000	-$2,304,000	-20%	30 Sep 2023	10-Q	09 Nov 2023	2023	Q3
Q2 2023	$9,629,000	-$2,058,000	-18%	30 Jun 2023	10-Q	08 Aug 2023	2023	Q2
Q1 2023	$10,187,000	+$250,000	+2.5%	31 Mar 2023	10-Q	09 May 2023	2023	Q1
Q4 2022	$10,785,000			31 Dec 2022	10-K	05 Mar 2024	2023	FY
Q3 2022	$11,307,000			30 Sep 2022	10-Q	08 Nov 2022	2022	Q3
Q2 2022	$11,687,000			30 Jun 2022	10-Q	09 Aug 2022	2022	Q2
Q1 2022	$9,937,000			31 Mar 2022	10-Q	06 May 2022	2022	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.